» Articles » PMID: 8831597

Surgical Resection of Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Value of Preoperative Portal Pressure

Overview
Specialty Gastroenterology
Date 1996 Oct 1
PMID 8831597
Citations 225
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Although resection of hepatocellular carcinoma complicating cirrhosis is restricted to patients with preserved liver function, postoperative hepatic decompensation develops in some patients. The aim of this study was to determine the value of increased portal pressure in the development of postoperative hepatic decompensation.

Methods: Twenty-nine cirrhotic patients with Child-Pugh's class A disease and hepatocellular carcinoma (all except one < 5 cm) scheduled to undergo resection were evaluated by conventional criteria and by a systemic and hepatic hemodynamic study. Predictors of decompensation were assessed among a series of 44 clinical, analytical, tumoral, and hemodynamic parameters.

Results: Eleven patients had unresolved decompensation 3 months after surgery. Bilirubin and blood ureic nitrogen levels, platelet count, wedged hepatic venous pressure, hepatic venous pressure gradient, and indocyanine green intrinsic clearance were significantly associated with unresolved decompensation, but only hepatic venous pressure gradient was significant, in the multivariate analysis (P = 0.0001; odds ratio, 1.90; 95% confidence interval, 1.12-3.22). The preoperative gradient of patients with unresolved decompensation was higher than that of patients without it (13.9 +/- 2.4 and 7.4 +/- 3.5 mm Hg, respectively; P < 0.001).

Conclusions: Cirrhotics with increased portal pressure are at high risk of hepatic decompensation after resection of hepatocellular carcinoma. Surgical resection should therefore be restricted to patients without portal hypertension.

Citing Articles

[Hepatocellular carcinoma (HCC)].

Pol S Med Trop Sante Int. 2025; 4(4).

PMID: 40070978 PMC: 11892391. DOI: 10.48327/mtsi.v4i4.2024.614.


Non-invasive assessment of portal hypertension: Liver stiffness and beyond.

Mandorfer M, Abraldes J, Berzigotti A JHEP Rep. 2025; 7(3):101300.

PMID: 40034396 PMC: 11874574. DOI: 10.1016/j.jhepr.2024.101300.


Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failure.

Ammann M, Jonas J, Pereyra D, Santol J, Hackl H, Kalchbrenner T Hepatobiliary Surg Nutr. 2025; 14(1):49-65.

PMID: 39925909 PMC: 11806138. DOI: 10.21037/hbsn-24-464.


Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.

Yuan Y, Peng H, He W, Zheng Y, Qiu J, Chen B Cancer Commun (Lond). 2024; 44(11):1337-1349.

PMID: 39322951 PMC: 11570767. DOI: 10.1002/cac2.12614.


Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.

Hou H, Liang L, Deng L, Ye W, Wen Y, Liu J Int J Gen Med. 2024; 17:2877-2886.

PMID: 38947567 PMC: 11214568. DOI: 10.2147/IJGM.S464083.